Teva stock nearing the end of shuffling - Follow Up

Teva stock acted in accordance with the original forecast and broke into the upper area of ​​a bullish symmetric expanding triangle pattern, the signs of money coming in from strong parties continue to be expressed through our technical tools and the expectation is still positive about the stock. A drop below the level of 6,600 will require a re-examination of the stock and a renewed technical analysis

Attached is a daily graph of the Teva share price in trading on the Israeli Stock Exchange in Tel Aviv:

 

 :Attached is the original review

Teva's technical structure created an expanding triangle pattern while breaking new highs with increasing trading volume, a fact which can be interpreted as strengthening the high price at which trading closed on the day a higher record was set. The breakout of wave D will be confirmation of the continued strengthening of the stock price.

A drop below the wave E, price 6000, will cancel the pattern and require a new analysis

 Attaching a few words about the company, a company that has suffered severe blows in recent years ranging from illusory deals in South America to huge lawsuits in the US as a result of consumer addiction to opioids, lawsuits that resulted in billions in financial damages as a result of the court rulings that convicted Teva in the opioid case.

 Teva offers a full spectrum of products from generics, innovative and biosimilar medicines, to over-the-counter treatments. 

Teva was established in 1901. TEVA global headquarters are based in Israel. TEVA have a portfolio of more than 3,600 medicines, and produce approximately 76 billion tablets and capsules a year. TEVA have over 53 manufacturing facilities in more than 33 countries.